GnRH I (Human) [3740]



GnRH I (Human)


SMILES CC(C)CC(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1cnc[nH]1)NC(=O)C1CCC(=O)N1)C(=O)N1CCCC1C(=O)NCC(N)=O
InChIKey NMJREATYWWNIKX-UHFFFAOYSA-N
Sequence XHWSYGLRPG
HELM PEPTIDE1{[*C(=O)C1CCC(=O)N1 |$_R2;;;;;;;;$|].(H,[dH]).(W,[dW]).(S,[dS]).(Y,[dY]).G.(W,[dW]).(L,[dL]).(P,[dP]).G.[am]}$$$$V2.0

Chemical Properties

Hydrogen bond acceptors 14
Hydrogen bond donors 15
Rotatable bonds 29
Log P -1.717
Molecular weight (Da) 1211.6
Stereochemistry info unspecified


Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

GnRH I (Human)


Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.